The American Society of Anesthesiologists (ASA) has formally endorsed the SmartTots Consensus Statement, released December 14, 2012. The consensus statement now carries the endorsement of the International Anesthesia Research Society (IARS), US Food and Drug Administration (FDA), the American Academy of Pediatrics (AAP), the Society for Pediatric Anesthesia, the Society for Neuroscience in Anesthesia & Critical Care (SNACC) and European Society of Anesthesiology (ESA).
- Increasing the interval between repeated anesthetic exposures reduces long‐lasting synaptic changes in late post‐natal mice
- Tau Contributes to Sevoflurane-induced Neurocognitive Impairment in Neonatal Mice
- Neonatal exposure to sevoflurane expands the window of vulnerability to adverse effects of subsequent exposure to sevoflurane and alters hippocampal morphology via decitabine-sensitive mechanisms
- Sevoflurane Post-Conditioning Ameliorates Neuronal Deficits and Axon Demyelination After Neonatal Hypoxic Ischemic Brain Injury: Role of Microglia/Macrophage
- Behavior and Regional Cortical BOLD Signal Fluctuations Are Altered in Adult Rabbits After Neonatal Volatile Anesthetic Exposure